Annual Review 2018
Total Page：16
File Type：pdf, Size：1020Kb
Annual Review 2018 Contents Contents Introduction from the chair and chief executive 04 About us 05 Our vision and values 06 Performance and achievements 07 Health secretary visits Royal Brompton 08 New partnership to deliver world class care for heart and lung patients 09 The Darwin programme 10 Our specialist heart services in 2018 16 Our specialist lung services in 2018 22 A dedicated service for children and young people 28 A smooth transition: supporting young people moving from child to adult services 35 Record-breaking year for Harefield transplants 37 Harefield site transformed 40 Research highlights 42 Medical education 44 Listening to our patients 46 Emergency preparedness 48 Rehabilitation and therapies 50 Our charities 52 The healing arts 54 Our profile in the media 56 Governance 58 Trust accounts for year ended 31 March 2018 60 Other formats If you would like a copy of this report in another format, please contact the communications team at [email protected] or on 020 7352 8121. [email protected], 020 7352 8121 Bu raporun Türkçe kopyası için lütfen komunikasyon bölümündeki communications team ’la görüsün. [email protected], 020 7352 8121. If you would like a copy of this report in large print, please contact the communications team at [email protected] or on 020 7352 8121. Annual Review 2018 3 Introduction Introduction from the chair and chief executive with a total artificial heart the challenge set by eliminating the need for any programme, and our Darwin to all teams has overnight stay at all. More cystic fibrosis experts are been embraced across than 90 per cent of patient pioneering opportunities the organisation. feedback has been positive. in remote digital care. You will read about both A key area of focus It is our focus on initiatives in this review, has been on reducing transforming and and many others. the length of stay after advancing treatment for procedures and getting patients with heart and In partnership with patients back to their lung disease that is the academic institutions, the homes and families sooner. inspiration behind our pharmaceutical industry planned collaboration with Baroness Sally Morgan - chair and device manufacturers, So at Harefield Hospital King’s Health Partners1 (page our teams work hard to cardiology patients can 9). Our clinical teams have harness new technology now have an invasive been working together and deliver the very highest procedure, recover in a over the past 12 months standards of patient care. comfortable chair and to design a new approach This year alone over 2,000 go home the same day, which we think can patients were recruited to thanks to an innovative revolutionise heart and lung 200 research programmes new ‘lounge’ developed care and research in the UK. that will contribute towards by our specialists. The We are working to redesign better patient care and cardiology lounge provides how we deliver services, outcomes, and our teams a quiet, comfortable research and education attracted more than space, where patients across the partnership and £7.9 million in external relax in lounge chairs as beyond – from services Bob Bell - chief executive grants for research. they recover from their in the community, to procedure in the cardiac specialist inpatient care, to The year has also seen catheter laboratories. laboratory-based research. It is with a great deal of significant advances personal pride that we in the way we deliver Patients have been This year will see a major present this annual review. care as a result of a enthusiastic about the new public consultation on our It reflects a year major transformational lounge, with 100 per cent of plans and we look forward that brought many programme Trust-wide. those surveyed after their to working with patients achievements and some The Darwin programme visit saying they were “very and staff on this bold notable improvements reviews how we provide satisfied” with the service. and exciting partnership in patient care. our specialist services and which has the potential through comprehensive And at Royal Brompton to benefit up to 15 million Few NHS organisations engagement with staff Hospital the Squire Centre children and adults in can celebrate being at and patients, ensures best offers patients the chance London and beyond. We the forefront of medical practice becomes standard to come in to hospital on look forward to updating innovation for over 175 practice, identifies and the day of a procedure you on our progress. years, but for our Trust, removes inefficiencies, (such as angioplasty) rather the responsibility to and in some cases than stay the night before. push boundaries and completely redesigns the break new ground in treatments we offer. The centre combines a Bob Bell treating heart and lung pre-assessment clinic with disease lies at our core. There have been some a day-case unit, and almost impressive milestones two thirds of patients seen Today we are the only Baroness Sally Morgan in the programme’s first in the unit have been able NHS trust in the country year of operation and to go home the same day, 31 January 2019 1 King’s Health Partners comprises Guy’s and St Thomas’, King’s College Hospital, and South London and Maudsley NHS Foundation Trusts and King’s College London University 4 Royal Brompton & Harefield NHS Foundation Trust About us About us Royal Brompton & Harefield NHS Foundation Trust is the largest specialist heart and lung centre in the UK and one of the largest in Europe. The Trust is a partnership of the first coronary stent, founding By recruiting the best clinical and two hospitals – Royal Brompton the largest centre for cystic fibrosis non-clinical staff and investing in in Chelsea, West London, and in the UK, and pioneering intricate their development, we maintain our Harefield, near Uxbridge – which heart surgery for newborn infants. position as the leading UK provider of are each known throughout the respiratory care and a national leader world for their expertise, standard We carry out some of the most in the specialist areas of paediatric of care, and influential research. complex surgery, and offer some of cardiorespiratory care, congenital the most sophisticated treatment that heart disease and cystic fibrosis. As a specialist trust, we exclusively is available anywhere in the world. treat people with heart and lung We treat patients from all over the We work closely with academic disease – this means our doctors, UK and other countries, many of and industry partners to play a nurses and other healthcare staff are whom are unique in their medical leading role in pushing forward the experts in their chosen field, with needs, and demand for our services boundaries of medicine through many of them moving to us from continues to grow year-on-year. research, and by sharing what around the world so that they can we know through teaching, we develop their skills even further. Our fetal cardiologists can perform can help patients everywhere. scans at just 12 weeks, when a Over the years our experts have baby’s heart valve is just over a Our values (page 6) guide and been responsible for major medical millimetre in size, and our clinical support every decision we make breakthroughs including performing teams regularly treat patients to ensure our care is safe, of the the first successful heart/lung well into their 90s and help them highest quality and – crucially – transplant in Britain, implanting maintain a good quality of life. available to everyone who needs it. Annual Review 2018 5 Our vision and values Our vision and values Our vision is to be the UK’s leading specialist centre for heart and lung disease, developing services through research and clinical practice to improve the health of people across the world. The Trust will achieve this vision by: • improving patient safety and satisfaction • providing world class specialist treatments that others cannot offer • bringing innovation to clinical practice through our research partnerships • attracting, developing and retaining world class clinical leaders • investing in services, technologies and facilities to support new service models at both sites. We are supported in this by active patient and community groups who enthusiastically encourage and challenge us to deliver our goals. Our three core values are: And the following values support us in achieving them: Our values We care We believe in our staff At the heart of any We believe our patients deserve the organisation are its best possible specialist treatment for We believe our staff should feel valued values: belief systems their heart and lung condition in a and proud of their work and know that that are reflected in clean, safe place. we will attract and keep the best people thought and behaviour. When values are by understanding and supporting them. successfully integrated We respect throughout an We are responsible organisation, the result We believe that patients should be is a shared outlook and treated with respect, dignity and We believe in being open about where consequent strength, courtesy, and that they should be well our money goes, and in making our from performance informed and involved in decisions hospitals environmentally sustainable. through the style of about their care. We always have time communications to listen. We discover to the behaviour of employees. We are inclusive We believe it is our duty to find and develop new treatments for heart and lung disease, both Our values were We believe in making sure our for today’s patients and for future generations. developed by staff for specialist services can be used by staff. We have three everyone who needs them, and We share our knowledge core patient-facing we will act on any comments values and four others and suggestions which can help We believe in sharing what we know which support them.